Cancer treatment is being hampered by a deficiency in the number of women participating in cancer clinical trials.
This is the finding of a recent study due to be published in Cancer, the publication of the American Cancer Society in the July 15th, 2009 issue.
A team at the University of Michigan, led by Dr Reshma Jagsi, conducted the analysis of over 660 cancer clinical trials that took place in 2006.
In excess of a million individuals participated in the trials but the male and female ratio did not match the respective number of women afflicted with cancers that are not gender-specific.
According to the authors: "Only by understanding the forces affecting the sex distribution of study subjects can we as a society succeed in ensuring that our medical research efforts are inclusive and to the benefit of all."
Earlier this month (June 1st) researchers at the University of Michigan Comprehensive Cancer Center identified a blood pressure drug that could suppress up to 20 per cent of breast cancers.
What's better? Private or NHS healthcare?